SPP1 and colorectal cancer: Furthermore, analysis of SPP1 RNA expression in patients with colorectal cancer who have received FOLFOX treatment revealed higher SPP1 expression in patients who have experienced recurrence compared with patients with no tumor recurrence, which suggests that inhibiting SPP1 expression may represent a novel approach by which to prevent tumor recurrence.